Sunday, March 17, 2019

FDA Approves Immunotherapy Drug for Triple-Negative Breast Cancer - Healthline

FDA Approves Immunotherapy Drug for Triple-Negative Breast Cancer  Healthline

The U.S. Food and Drug Administration recently granted accelerated approval to the first immunotherapy treatment for breast cancer. It combines the drug ...

(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment